Abstract:Introduction: Disseminated intravascular coagulation (DIC) is an acquired syndrome characterized by the widespread activation of coagulation. This leads to failure of multiple organs in the body and finally death. Because there is no effective therapy for DIC, the clinical prognosis is poor and the mortality is high.Materials and Methods: The animals were intravenously injected with Lipopolysaccharide (LPS) for 6 hours and simultaneously infected three doses of recombinant fibrinogenase II (rFII) for 2 hour. Activated partial thromboplastin time (AMT), prothrombin time (PT), platelets count, fibrinogen and fibrin-fibrinogen degradation products (FDP) were determined. The plasma levels of alanine ami notransferase (ALT), creatinine (Cr) and tumor necrosis factor-alpha (TNF-alpha) were detected, Liver and kidney samples were stained with hematoxylin-eosin and kidney sections were stained with phosphotungstic acid-hematoxylin.Results: We observed that rFII increased survival rate in LPS-induced DIC rabbits as well as heparin did. Administration of rFII as well as heparin attenuated the increased plasma levels of APTT, PT and FDP and the decreased plasma level of fibrinogen at 6 h. rFII reduced hepatic and renal damages and decreased the levels of ALT and Cr as well as heparin did. rFII also significantly reduced the increased plasma levels of TNF-alpha rFII significantly reduced the kidney fibrin deposits with respect to LPS treated animals.Conclusions: Our findings suggest that rFII from Agkistrodon acutus venom could have protective effect on DIC via reducing liver and renal damages and direct degradation of microthrombi. (C) 2008 Elsevier Ltd. All rights reserved.

Corrigendum to “A Novel Fibrinogenase from Agkistrodon Acutus Venom Protects Against DIC Via Direct Degradation of Thrombosis and Activation of Protein C” [biochem. Pharmacol. 84 (2012) 905–913]

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Corrigendum to "Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system" [Heliyon Volume 10, Issue 10, 30 May 2024, Article e30969]

A Novel Fibrinogenase from Agkistrodon Acutus Venom Protects Against DIC Via Direct Degradation of Thrombosis and Activation of Protein C.

Corrigendum to “thrombin Promotes the Expression of Thrombospondin-1 and -2 in a Rat Model of Intracerebral Hemorrhage” [J Neurol Sci 323 (2012) 141–146]

Corrigendum to "Thiol-ene Michael-type formation of gelatin/poly(ethylene glycol) biomatrices for three-dimensional mesenchymal stromal/stem cell administration to cutaneous wounds" [Acta Biomater. 9(11) (2013) 8802-8814].

Novel Recombinant Fibrinogenase of Agkistrodon Acutus Venom Protects Against LPS-induced DIC.

Corrigendum to “the Induction of Reactive Oxygen Species and Loss of Mitochondrial Omi/HtrA2 is Associated with S-nitrosoglutathione-induced Apoptosis in Human Endothelial Cells” [toxicology and Applied Pharmacology 244 (2010) 374–384]

Correction: Corrigendum: Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury

Corrigendum To: Pathogenic Characteristics and Treatment in 43 Cases of Acute Colchicine Poisoning

WITHDRAWN: Corrigendum to “cerebral Angiogenesis after Collagenase-Induced Intracerebral Hemorrhage in Rats" [brain Res. 1175 (2007) 134–142]

Erratum: Gill JC, Castaman G, Windyga J, et al. Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease. Blood. 2015;126(17):2038-2046

Corrigendum to “Bioactivity-Guided Isolation of Cytotoxic Constituents of Brucea Javanica Collected in Vietnam” [bioorg. Med. Chem. 17 (2009) 2219]

[Corrigendum] Inhibition of BTK protects lungs from trauma-hemorrhagic shock-induced injury in rats

Corrigendum to "The ACE2/Ang-(1-7)/MasR axis alleviates brain injury after cardiopulmonary resuscitation in rabbits by activating PI3K/Akt signaling"

Corrigendum: Adiponectin-derived Active Peptide ADP355 Exerts Anti-Inflammatory and Anti-Fibrotic Activities in Thioacetamide-Induced Liver Injury.

Corrigendum: Comparison of "Huaxi-1" or "histidine-tryptophan-ketoglutarate" cardioplegia in an animal model

Corrections To: Soluble Production and Function of Vascular Endothelial Growth Factor/basic Fibroblast Growth Factor Complex Peptide

Correction: Corrigendum: Novel Anti-Thrombotic Agent for Modulation of Protein Disulfide Isomerase Family Member ERp57 for Prophylactic Therapy

Corrigendum to: Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein

Erratum to “Ameliorating Adriamycin-Induced Chronic Kidney Disease in Rats by Orally Administrated Cardiotoxin from Naja naja atra Venom”